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Abstract
Importance: Psychological and health-restorative benefits of mind-body therapies have been investigated, but their impact
on the immune system remain less defined.
Objective: To conduct the first comprehensive review of available controlled trial evidence to evaluate the effects of mind-
body therapies on the immune system, focusing on markers of inflammation and anti-viral related immune responses.
Methods: Data sources included MEDLINE, CINAHL, SPORTDiscus, and PsycINFO through September 1, 2013. Randomized
controlled trials published in English evaluating at least four weeks of Tai Chi, Qi Gong, meditation, or Yoga that reported
immune outcome measures were selected. Studies were synthesized separately by inflammatory (n = 18), anti-viral related
immunity (n = 7), and enumerative (n = 14) outcomes measures. We performed random-effects meta-analyses using
standardized mean difference when appropriate.
Results: Thirty-four studies published in 39 articles (total 2, 219 participants) met inclusion criteria. For inflammatory
measures, after 7 to 16 weeks of mind-body intervention, there was a moderate effect on reduction of C-reactive protein
(effect size [ES], 0.58; 95% confidence interval [CI], 0.04 to 1.12), a small but not statistically significant reduction of
interleukin-6 (ES, 0.35; 95% CI, 20.04 to 0.75), and negligible effect on tumor necrosis factor-a (ES, 0.21; 95% CI, 20.15 to
0.58). For anti-viral related immune and enumerative measures, there were negligible effects on CD4 counts (ES, 0.15; 95%
CI, 20.04 to 0.34) and natural killer cell counts (ES, 0.12, 95% CI 20.21 to 0.45). Some evidence indicated mind-body
therapies increase immune responses to vaccination.
Conclusions: Mind-body therapies reduce markers of inflammation and influence virus-specific immune responses to
vaccination despite minimal evidence suggesting effects on resting anti-viral or enumerative measures. These
immunomodulatory effects, albeit incomplete, warrant further methodologically rigorous studies to determine the clinical
implications of these findings for inflammatory and infectious disease outcomes.
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Introduction
Over the last two decades, mind-body therapies (MBTs),
including Tai Chi, Qi Gong, meditation, and Yoga have received
increasing awareness and attention from the scientific community
seeking to understand the safety and efficacy of these widely used
practices. According to the 2007 National Health Interview
Survey, 19% of American adults have used at least one mind-body
therapy in the past 12 months [1]. Currently, the National Center
for Complementary and Alternative Medicine designates MBTs as
a top research priority [2].
Previous work has shown that MBTs offer many psychological
and health functioning benefits including reductions in disease
symptoms, improvements in coping, behavior regulation, quality
of life, and well-being [3–22]. In light of these benefits, recent
investigations have sought to better understand the role of MBTs
on physiological pathways such as the immune system. It has been
well-established that psychological stress and depression impair
anti-viral immune responses and activate innate immunity or
markers of inflammation via effector pathways, such as the
sympathetic nervous system and the hypothalamus-pituitary-
adrenal (HPA) axis [23–28]. In fact, behavioral interventions
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targeted at alleviating stress, promoting heightened states of
relaxation, and encouraging moderate physical activity, have been
shown to bolster anti-viral immune responses and decrease
markers of inflammation, particularly among older adults or
adults experiencing high levels of psychological stress [3,17,18,29–
31].
The efficacy of such behavioral interventions in modulating the
immune system suggests that MBTs may also confer immuno-
modulatory benefits. Tai Chi, Qi Gong, and Yoga are multi-
dimensional behavioral therapies that integrate moderate physical
activity, deep breathing, and meditation to promote stress-
reduction and relaxation, which could potentially influence the
immune system [28]. Meditation, including more integrative,
mindfulness-based, stress-reduction programs, has also been
shown to regulate emotional and affective responses to stress,
and therefore may influence the immune system even in the
absence of physical activity [32].
To our knowledge, this study is the first comprehensive review
of the best available evidence, summarizing the effects of MBTs on
the immune system while focusing on two aspects of immunity that
are regulated by stress response mechanisms, namely inflamma-
tion and anti-viral related immune responses [28]. Based on these
findings, recommendations for future research are offered.
Methods
Data Sources and Searches
We searched MEDLINE (from 1946), CINAHL (from 1981),
SPORTDiscus (from 1985), and PsycINFO (from 1967) through
September 1, 2013. Searches were limited to human studies and
the English language (the full search strategy is described in Table
S1). We also screened the reference lists of selected reviews and
primary articles for additional publications and consulted experts
in the field. We did not search for unpublished studies.
Study Selection and Eligibility Criteria
All abstracts identified through the literature search were
screened with a low threshold to exclude irrelevant abstracts. Full-
text articles of potentially relevant abstracts were retrieved and
evaluated for eligibility by one investigator and confirmed by
another investigator. Study eligibility criteria are described in
Table 1.
Classification of the immune outcomes for this meta-analysis
was guided by functional genomics studies that have identified two
broad gene expression programs that can be induced in myeloid
lineage cells by different types of microbial stimulus, and that can
also be regulated by stress response mechanisms [28]. For
example, extracellular pathogens, such as bacteria, activate
transcription factors (i.e., nuclear factor-kB (NF-kB) and activator
protein 1 (AP1), which lead to increased expression of genes such
as interleukin-1b (IL-1B), interleukin-6 (IL-6), and tumor necrosis
factor (TNF). Together, activation of these inflammatory gene
programs leads to increases in cellular markers of inflammation
such as the pro-inflammatory cytokines IL-6, TNFa, and C-
reactive protein (CRP). In contrast, intracellular pathogens, such
as viruses, elicit a distinct antiviral gene program that involves the
induction of type I interferon (IFN) genes via transcription factors
such as interferon regulatory factors (IRFs). This anti-viral gene
expression program mediates fundamentally different effector
responses, which are categorized in this analysis to include
lymphocyte proliferation and response to vaccination. In addition
to these two broad categories of effector responses, enumerative
measures characterize the relative distribution of lymphocyte
subpopulations such as CD4 T-cells and NK cells.
Data Extraction and Quality Assessment
Data extraction and quality assessment were performed by one
investigator and confirmed by at least one other investigator.
Disagreements were resolved by consensus among team members.
We extracted information on study characteristics, population
characteristics, and type, duration, frequency of interventions and
immune outcomes. We also assessed the risk of bias for each study
using the Cochrane risk of bias tool [33], with an overall rating as
high, moderate, or low risk of bias (Table S2).
Synthesis and Analysis
We qualitatively synthesized all included studies in summary
tables. Studies were grouped into the following three categories of
immune outcomes, according to the role of the central nervous
system in regulating immune response genes programs and the
effects of sympathetic activation on these effector responses and
enumerative measures [28]: (1) Inflammatory (CRP, IL-6, TNF-a,
and IL-8); (2) Anti-viral (Interferon-c, lymphocyte proliferation,
viral antibodies, and natural killer (NK) cytotoxicity); and (3)
Enumerative measures (number of CD4 lymphocytes, NK cells,
and leukocytes) and other immune-related measures (e.g. comple-
ment, IgA). See Table 2 for the classifications.
Due to disparate measures in variable metrics, we calculated a
standardized mean difference (Cohen’s d) comparing mind-body
therapy with control (variable across studies). Table 3 summarizes
the technical details on the interpretations for effect size (ES). We
obtained missing or unclear data through various techniques (e.g.,
contacting authors, imputing missing standard deviations or
digitizing data from the result figures). Detailed information on
the techniques is available upon request. In view of significant
heterogeneity, the DerSimonian-Laird random-effect model was
Table 1. Study Eligibility Criteria.
Study Design Published data from randomized controlled trials
Population Adults, clinical or research populations
Intervention Tai Chi, Qi Gong, meditation, or Yoga interventions, or as these mind-body therapies as a major component of the intervention, with duration
of four weeks or longer. In studies that involved more than one active intervention, we restricted our analyses to the comparisons between
mind-body therapy intervention and control group. For meta-analysis, we used the time-point immediately following completion of the
intervention if multiple time-points were measured in a study
Comparator Any control
Outcome At least one immune outcome
Minimal sample size 10 participants
doi:10.1371/journal.pone.0100903.t001
Mind-Body Therapies and the Immune System
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e100903
Table 2. Summary of Evidence Reviewed Categorized by Inflammatory and Antiviral Outcomes.
Outcome of
Interest
Mind-body therapy study
[Reference]
Intervention
Duration
(Weeks)
Total
Sample Size
Analyzed
Risk of
Bias
Summary of Key Findings for the Effect of Mind-
body Therapies Compared with Control
Interventions
1. Inflammatory measures
CRP Chen 2010 (TC) [68], Creswell
2012 (Med) [37], Irwin 2012;
Irwin 2007 (TC) [60,61], Lavertsky
2011 (TC) [67], Malarkey 2013
(Med) [51], Oh 2012; Oh 2010;
Oh 2008 (QG) [72–74], Oken
2010 (Med) [43], Pullen 2010
(Yoga) [55], Pullen 2008 (Yoga)
[54]
7 to 16 710 4 Moderate;
5 Low
Finding 1. Our random-effects meta-analysis of 9 studies
showed a medium effect on decreasing CRP (ES 0.58, 95% CI
0.04 to 1.12, P = 0.035). There was a statistically significant
heterogeneity across studies (I2 = 97%, P,0.001). Finding
2. Stratified by clinical populations, the subgroup meta-
analysis showed that studies in healthy people were
homogenous and had an insignificant small effect on CRP
(ES 0.2, 95% CI. 20.13 to 0.53), with an I2 = 0%, while studies
in populations with disease conditions were heterogeneous
and showed a significant effect on CRP (0.74, 95% CI. 0.00 to
1.48]), with an I2 = 94%
IL-6 Chen 2006 (QG) [69],
Creswell 2012 (Med) [37],
Irwin 2012; Irwin 2007 (TC)
[60,61], Janelsins 2011[63],
Sprod 2012 (TC) [65], Malarkey
2013 (Med) [51], McCain 2008
(TC) [64], Oken 2010 (Med) [43],
Pace 2009 (Med) [44], Pullen
2008 (Yoga) [54], Pullen 2010
(Yoga) [55], Zautra 2008 (Med)
[49]
6 to16 594 2 High;
2 Moderate;
7 Low
Finding 1. Our random-effects meta-analysis of 10 studies
showed a small effect on decreasing IL-6 (ES 0.35, 95% CI 2
0.04 to 0.75, P = 0.08). There was a statistically significant
heterogeneity across studies (I2 = 83%, P,0.001). Stratified
by clinical populations, the subgroup meta-analysis showed
no significant difference in the pooled effect on IL-6
between studies in healthy people and those in the
population with disease conditions (ES 0.35 [95% CI. 20.22,
0.92] vs. 0.38 [95% CI. 20.23, 0.99], Pbetween = 0.91). Finding
2. 1 study not in meta-analysis reported ‘‘no significant
changes’’ in cytokine levels (data not reported) following 10
weeks of Tai Chi or wait-list control in HIV patients.
TNF-a Elsenbruch 2005 (Med) [40],
Manzaneque 2009 (QG) [71],
McCain 2008 (TC) [64], Oken
2010 (Med) [43], Rao 2008 -2
articles (Yoga) [56,59]
4 to 10 415 2 High;
1 Moderate;
2 Low
Finding 1. Our random-effects meta-analysis of 3 studies
showed a negligible to small effect on TNF-a (ES 0.21, 95%
CI 20.15 to 0.58, P = 0.25). There is no significant
heterogeneity across studies (I2 = 0%, P = 0.75). Finding 2. 2
studies not in meta-analysis both reported no significant
changes in TNF-a comparing mind-body therapies to
control interventions.
IL-8 Janelsins 2011 [63], Sprod
2012 (TC) [65], Barrett 2012
(Med) [36], Rozenkranz 2013
(Med) [45]
8 to12 158 1 High;
2 Low
1 study showed significant increases in IL-8 from nasal wash
during upper respiratory infection while 2 studies showed
no significant change in IL-8 from serum or blister fluid.
2. Anti-viral measures
IFN-c Gopal 2011 (Yoga) [53],
Janelsins 2011 [63], Sprod
2012 (TC) [65], Manzaneque
2009 (QG) [71], McCain 2008
(TC) [64]
4 to 12 228 1 High;
1 Moderate;
2 Low
3 studies (two in healthy individuals and one in breast
cancer survivors) found no significant differences in
cytokines (including IFN- c), while one study found a large
significant effect on IFN- c among participants with HIV.
Lymphocyte
Proliferation
and
vaccination
responses
Irwin 2003 (TC) [62], Irwin
2012; Irwin 2007 (TC) [60,61],
McCain 2008 (TC) [64],
Davidson 2003 (Med) [39]
8 to 16 318 3 Low;
1 High
Finding 1. 1 study found no significant effect immediately
post-intervention but the overall lymphocyte function
significantly improved versus control group at 6-month
follow-up in patients with HIV. Finding 2. 2 studies showed
a significant effect on VZV-RCF at rest and in response to
vaccination in healthy older adults. Finding 3. 1 study also
found significant increases in influenza antibody titer
following influenza vaccination in healthy adults.
NK
Cytotoxicity
McCain 2008 (TC) [64] 10 252 1 Low 1 study showed no significant change in NK cytotoxicity.
3. Enumerative measures
CD4
Lymphocytes
Cade 2010 (Yoga) [52],
Creswell 2009 (Med) [38],
Elsenbruch 2005 (Med) [40],
Hidderley 2004 (Med) [42],
Lengacher 2013 (Med) [50],
Manzaneque 2004 (QG) [70],
McCain 2008 (TC) [64],
SeyedAlinaghi 2012 (Med) [46],
Solberg 1995 (Med) [47],
Taylor 1995 (Med) [48],
Wang 2011 (TC) [66]
4 to 20 777 8 High;
1 Moderate;
2 Low
Finding 1. Our random-effects meta-analysis of 7 studies
showed a negligible to small effect on the number of CD4+*
T lymphocytes (ES 0.15, 95% CI 20.04 to 0.34, P = 0.13).
There is no significant heterogeneity across studies (I2 = 0%,
P = 0.79). Finding 2. 3 studies (1 in healthy individuals and
1 in HIV patients) reported no significant changes in the
number of CD4*+ T lymphocytes, and 1 study in healthy
college students reported a significant increased in CD4+ T
lymphocyte count in Tai Chi but not in control group.
Mind-Body Therapies and the Immune System
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used for pooling [34]. Heterogeneity was estimated with the
Cochran Q statistic (considered significant when the P value was
less than 0.10) and quantified the extent of heterogeneity with the
I2 index [35]. To explain the heterogeneity across studies, we
conducted subgroup meta-analyses stratified by 1) clinical
populations (healthy or with diseases), 2) types of MBTs (Tai
Chi/Qi Gong, Yoga, or meditation), and 3) types of controls
(defined by the original studies). The difference between subgroups
was tested using a z-test. All analyses were conducted by using
Stata SE 12 software (Stata Corp., College Station, Texas).
Results
Figure 1 depicts the literature search and study selection
process. A total of 34 unique studies within 39 articles published
from 1995–2013 were ultimately included.
Table 2 summarizes the evidence reviewed according to types
of outcomes. Of the 34 studies (published in 39 articles) [36–74],
16 of them evaluated meditation as the primary intervention [36–
51], 7 evaluated Yoga [52–59], 7 evaluated Tai Chi [60–68], and
4 evaluated Qi Gong [69–74]. There were 984 healthy individuals
(n = 17), and 1365 patients with chronic conditions such as: cancer
(n = 5), HIV (n= 5), cardiovascular risk or disease (n = 3),
depression (n= 1), diabetes (n = 1), rheumatoid arthritis (n = 1),
and ulcerative colitis (n = 1). Mean age ranged from 21 to 70 years.
Frequency and duration of interventions ranged from one to seven
times/week for four to twenty weeks. Controls were varied,
including wait-list, routine activity, and standard medical care.
Table 4 describes the characteristics of the 34 included studies.
Twenty one of the 34 studies were meta-analyzed for one or
more outcomes (Figure 1). We describe below results for each
outcome separately for studies that provided data for meta-analysis
and those excluded from meta-analysis.
1. Inflammatory Outcomes
Eighteen studies published in 22 articles
[11,36,37,40,43,45,49,51,54–56,59–61,64,65,67–69,71–74] with
a total of 1,667 participants reported data on the effects of MBTs
on inflammatory outcomes (i.e. CRP, IL-6, TNF-a, and IL-8). Of
these 18 studies, four were rated at high risk, five at moderate risk,
and nine at low risk of bias.
a. CRP. Nine studies [37,43,51,54,55,60,61,67,68,72–74]
evaluated the effects of MBTs [meditation (n= 3), Tai Chi
(n = 3), Qi Gong (n= 1), and Yoga (n= 2)] on CRP in 710
participants with a variety of clinical conditions (heart failure
[54,55], Type 2 diabetes [68], major depression [67], healthy
individuals [37,43,60,61], elderly participants with cardiovascular
disease risk factors [51], or cancer patients [72–74]). Various
controls were compared among the nine trials including, wait-list
(n = 1); aerobic activity (n = 1); education (n= 4); and usual care
(n = 3).
Our meta-analysis showed that 7 to 16 weeks (1 to 3 times/week
totaling 60 to 180 minutes weekly) of MBTs demonstrated
medium effect and statistically significant improvements on CRP
compared with control interventions (ES 0.58, 95% CI. 0.04 to
1.12, P= 0.04) (Figure 2, panel a), with an I2 = 97%. Stratified
by clinical populations, the subgroup meta-analysis showed that
studies in healthy individuals were homogeneous and showed an
insignificant effect on CRP (ES 0.2, 95% CI. 20.13 to 0.53), with
an I2 = 0%. On the contrary, studies in populations with disease
conditions were heterogeneous and showed a significant effect on
CRP (ES 0.74, 95% CI. 0.00 to 1.48), with an I2 = 94% (Figure 3,
panel a). However, the difference in the pooled effect sizes
between the two subgroups was not significant (Pbetween = 0.34).
Further subgroup analysis exploring the effects of different
MBTs on CRP showed that studies of Tai Chi/Qi Gong had
larger but more heterogeneous mean effect sizes (ES 0.78, 95% CI.
–0.24 to 1.80; I2 = 96%) compared with studies of meditation (ES
0.40, 95% CI. 0.02 to 0.77; I2 = 41%). The single study that
investigated Yoga found an insignificant effect on CRP (ES 0.20,
95% CI. –0.70 to 1.10) (Figure 3, panel c).
We also performed a subgroup meta-analysis on CRP by types
of controls. The results showed that the effect sizes ranged widely
across different types of controls (Figure 3, panel e).
b. IL-6. Eleven studies [37,43,44,49,51,54,55,60,61,63–65,69]
evaluated the effects of 6 to 16 weeks of MBTs [meditation (n= 5),
Tai Chi (n = 3), Yoga (n= 2), and Qi Gong (n = 1)] on IL-6. Ten
studies with 565 participants were included in our meta-analysis
[37,43,44,49,51,54,55,60,61,63,65,69], but one study with 125
participants lacked sufficient quantitative detail for meta-analysis
[64]. Among the eleven trials, various control conditions included:
wait-list (n = 1); aerobic activity (n = 1) and social support (n = 1);
education (n= 6); and usual care (n = 2).
Our meta-analysis of ten studies showed that 6 to 16 weeks (1 to
3 times/week totaling 60 to 180 minutes of weekly instructions) of
MBTs demonstrated a small, but not statistically significant effect
on IL-6 (0.35, 95% CI - 0.04 to 0.75, P = 0.08) compared with
control interventions (Figure 2 panel b), with an I2 = 83%.
Stratified by clinical populations, the subgroup meta-analysis
showed no significant difference in the pooled effect on IL-6
Table 2. Cont.
Outcome of
Interest
Mind-body therapy study
[Reference]
Intervention
Duration
(Weeks)
Total
Sample Size
Analyzed
Risk of
Bias
Summary of Key Findings for the Effect of Mind-
body Therapies Compared with Control
Interventions
NK Cells Elsenbruch 2005 (Med) [40],
Hidderley 2004 (Med) [42],
Lengacher 2013 (Med) [50]
6 to 8 143 3 High Our random-effects meta-analysis of 3 studies showed a
negligible to small effect on the number of NK cells ES 0.12,
95% CI 20.21 to 0.45, P = 0.47). There is no significant
heterogeneity across studies (I2 = 0%, P = 0.48)
Salivary IgA Fan 2010 (Med) [41],
Vogler 2011 (Yoga) [58]
4 to 8 73 2 High 1 study reported a significant increase in salivary IgA
compared to the control (P = 0.03), and another study
reported no significant difference in salivary IgA between
groups.
Total blood
count
Subramanian 2012 (Yoga) [57] 6 40 1 High 1 study reported a decrease in neutrophils (P,0.01) and
increase in lymphocytes (P,0.01) compared to the control
group.
doi:10.1371/journal.pone.0100903.t002
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between studies in healthy individuals and those with disease
conditions (ES 0.35 [95% CI. 20.22, 0.92] vs. 0.38 [95% CI. 2
0.23, 0.99], Pbetween = 0.91) (Figure 3, panel b).
Similar to CRP, studies of Tai Chi/Qi Gong (ES 0.35, 95% CI.
20.47 to 1.18; I2 = 84%) and Yoga (ES 1.37, 95% CI. 20.57 to
3.31; I2 = 90%) had larger but more heterogeneous mean effect
sizes on IL-6 compared with that of meditation (ES 20.05, 95%
CI. 20.16 to 0.06; I2 = 0%) (Figure 3, panel d). The meta-
analysis also showed that the effect sizes on IL-6 ranged widely
across different types of controls (Figure 3 panel f).
One study in HIV patients’ self- reported ‘‘no significant
changes’’ in cytokine levels (no data in meta-analysis) following 10
weeks of Tai Chi or wait-list control [64]. Overall, 11 studies
suggest that MBTs were associated with small but not significant
effects on IL-6 compared with control interventions.
c. TNF-a. Five studies [40,43,56,59,64,71] evaluated the effects
of 4 to 10 weeks of MBTs [meditation (n= 2), Qi Gong (n = 1), and
Yoga (n= 1)] on TNF-a. Three studies with 121 participants were
included in our meta-analysis [40,43,56,59,64,71], while two
studies with 84 participants lacked sufficient quantitative detail and
were not included in the analysis [40,43,56,59,64,71].
Our meta-analysis of three studies showed that 4 to 7 weeks (1
to 7 times/week totaling 90 to 210 minutes weekly) of MBTs
showed a negligible to small effect on TNF-a (ES 0.21, 95% CI. –
0.15 to 0.58, P = 0.25) (Figure 2, panel c), with an I2 = 0%. The
two studies which were not included in the meta-analysis reported
no significant differences in TNF-a after 10 weeks of meditation
[40] or Tai Chi [64]. Together, these five studies suggest that
MBTs do not have a significant effect on TNF-a, compared with
control interventions.
d. IL-8. For IL-8, three studies [36,45,63,65] with a total of
158 participants were identified. Meta-analysis could not be
performed due to insufficient data. One study of 149 healthy
adults, rated at low risk of bias, found that eight weeks of
meditation (2.5 hours, 1 time/week) led to significantly higher
levels of IL-8 in nasal wash collected during acute respiratory
infection compared to control (P = 0.02) [36]. The other two (one
rated at low risk [63] and one at high risk [45]) reported that 10
Table 3. Technical details on the interpretations for effect size (ES).
Direction of the ES For consistency in the direction of ES across immune parameters, we calibrated the effect sizes for inflammatory markers with a
negative orientation, such that an increase in effect corresponded to a reduction in inflammatory marker comparing mind-body
therapy with control, by multiplying the mean change from baseline by (21).
Magnitude of the ES The magnitude of the ES (clinical effects) indicates: 0–0.19 = negligible effect, 0.20–0.49 = small effect, 0.50–0.79 =moderate effect, and
0.80(+) = large effect [103,104].
doi:10.1371/journal.pone.0100903.t003
Figure 1. Literature Search and Study Selection. Legends: CD4= cluster of differentiation 4 protein; CRP= c-reactive protein; IL-6 = interleukin-
6; INF-c= Interferon-gamma; NK count = natural killer cell count; TNF-a= Tumor necrosis factor. aThe studies were conducted in 9 countries (United
States, China, India, Australia, Spain, Germany, Iran, Norway, and the United Kingdom). bThe sum of study number exceeds the total number of
studies included due to some studies reported multiple outcomes across categories.
doi:10.1371/journal.pone.0100903.g001
Mind-Body Therapies and the Immune System
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and 12 weeks of Tai Chi or meditation did not show significant
changes in IL-8 compared with control interventions.
Overall, MBTs were positively associated with decreased CRP
levels in patients with type 2 diabetes, cancer, or heart failure, and
the elderly with depression and cardiovascular disease risk factors.
Small but insignificant improvements were also noted in levels of
IL-6. The impact of mind-body therapies on TNF-a and IL-8
remains uncertain.
2. Anti-Viral Related Outcomes
A total of seven studies published in nine articles [39,53,60–
65,71] reported data on the effects of MBTs on anti-viral
outcomes such as IFN-c (n = 4), lymphocyte proliferation includ-
ing viral-specific, cell-mediated immune responses (i.e., varicella
zoster virus responder cell frequency) [VZV-RCF] (n= 3), viral
antibodies (n = 1), and NK cytotoxicity (n = 1). Studies evaluated 4
to 16 weeks of meditation (n= 1), Tai Chi (n = 4), Yoga (n= 3), and
Qi Gong (n= 3). Due to the paucity of studies and heterogeneity of
outcomes, meta-analysis could not be performed.
For IFN-c, four studies [Tai Chi (n = 2), Qi Gong (n= 1), and
Yoga (n= 1)] with 228 participants and a variety of clinical
conditions (healthy individuals, HIV positive patients, and breast
cancer survivors) were identified [53,63–65,71]. Three studies (two
with healthy individuals and one with breast cancer survivors)
found no significant differences in cytokines (including IFN-c)
comparing mind-body therapy with controls [53,63,65,71]. On
the contrary, one study which compared Tai Chi (90 minutes, 1
time per week) with wait-list control found a large significant effect
on IFN-c among 119 patients with HIV. The study was rated low
risk of bias [64].
For lymphocyte proliferation and vaccination responses, four
studies [three Tai Chi (all rated at low risk of bias) and one
meditation (rated at high risk of bias)] were identified
[39,60–62,64]. One study evaluated the effect of Tai Chi on
lymphocyte function (measured by lymphocyte proliferation
assays) in patients with HIV [64]. The overall lymphocyte function
significantly improved as compared to the control group at six-
month follow-up. Two other studies compared effects of Tai Chi
versus health education on VZV-RCF in 148 healthy older adults,
and both found a significant effect on VZV-RCF at rest [60,62]
and in response to vaccination [61]. Finally, one other study also
examined anti-viral antibodies following influenza vaccination by
comparing an eight-week meditation with the wait-list control
among 41 healthy adults [39]. Although rated at high risk of bias,
Figure 2. Meta-analysis of RCTs comparing the effect of mind-body therapies with control interventions on inflammatory markers:
CRP (panel a), IL-6 (panel b), and TNF-a (panel c). Legends: CRP= c-reactive protein; IL-6 = interleukin 6; Med=meditation; QG=Qi Gong;
TC = Tai Chi; TNF-a=Tumor necrosis factor; Tx = treatment; RA= rheumatoid arthritis; SMD= standardized mean difference. Risk of bias: L = low;
M=medium; H= high (see Table S2 for details). Zautra 2008 reported only subgroup results (grp 1 =RA patients with depression; grp 2 = RA patients
without depression) and data from each subgroup were entered in the meta-analysis separately. P-values adjacent to I-squared results are p-values
for heterogeneity testing (P,0.05 indicates significant heterogeneity), and p-values adjacent to meta-analysis pooled results (diamonds) are p-values
for the pooled effect sizes.
doi:10.1371/journal.pone.0100903.g002
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this study reported significantly greater increases in anti-influenza
antibody titers at the four week and eight-week follow-up
compared with the control.
For NK cytotoxicity, only one study of 119 HIV patients [64],
rated at low risk of bias, reported that Tai Chi (90 minutes, 1 time
per week) had an insignificant effect on NK cytotoxicity compared
with wait-list control.
3. Other enumerative Outcomes
A total of 14 studies [38,40–42,46–48,50,52,57,58,64,66,70]
reported data on the effects of MBTs on enumerative outcomes,
such as CD4 cells (n = 11), NK cells (n = 4), salivary IgA (n = 2),
and total blood count (n = 1). Of these 14 studies, 11 were rated at
high risk, one at moderate risk, and two at low risk of bias.
Eleven studies [38,40,42,46–48,50,52,64,66,70] evaluated the
effects of MBTs on CD4 in a total of 676 participants with diseases
(HIV, breast cancer, and ulcerative colitis) and 101 healthy
individuals. Our meta-analysis of seven studies with diseases
showed that 6 to 10 weeks of meditation (1 to 2 times/week
totaling 60 to 360 minutes weekly) and a 20-week Yoga practice
(60 minutes, 2 to 3 times/week) had a negligible to small effect on
CD4 count (0.15, 95% CI 20.04 to 0.34, P= 0.13) (Figure 4
panel a), with an I2 = 0%. Four studies lacked sufficient
quantitative data and were not included in the meta-analysis. Of
these, two reported insignificant changes in CD4 count after four
weeks (30 minutes, 7 times/week) of Qi Gong [70] or seven weeks
(30 minutes, home practice) of meditation [47], compared with no
interventions. Another study in college students reported a
significant increase in CD4 count in Tai Chi (45 minutes, 5
times/week) but not in the control after 12 weeks [66]. The fourth
study of 252 adults with HIV found no significant differences in
the number of lymphocytes (CD4, CD8, and NK cells) between
Tai Chi (90 minutes, 1 time/week) and wait-list controls after 10
weeks [64].
Three studies [40,42,50] evaluated the effects of meditation on
NK counts in 30 patients with ulcerative colitis and 113 with
breast cancer. The durations of meditation ranged from six to
eight weeks (1 time per week totaling 60 to 360 minutes weekly).
Our meta-analysis showed that meditation had a negligible to
small effect on the number of NK cells (ES 0.12, 95% CI 20.21 to
0.45, P= 0.47) (Figure 4 panel b), with an I2 = 0%.
For other outcomes, three studies with 113 participants
reported data on the effects of MBTs [meditation (n= 1); Yoga
(n= 2)] on salivary IgA and total blood count [41,57,58].
Results from these three studies were mixed (Table 2). All
were rated at high risk of bias; thus no overall conclusion can be
drawn.
Discussion
This study extends our previous investigations of the effects of
Tai Chi on health outcomes [3,18–22], highlighting the promising
role that MBTs may play in regulating the immune system.
Overall, our findings suggest that MBTs may reduce inflamma-
tion, particularly among clinical populations, as evidenced by the
significant reductions in CRP. In addition, a few high quality
studies suggest that MBTs may increase virus-specific, cell-
mediated immunity at rest and in response to vaccinations. Thus,
the anti-inflammatory effects of MBTs, albeit incomplete, provide
Figure 3. Subgroup meta-analysis of RCTs comparing the effect of mind-body therapies with control interventions on CRP and IL-6
by clinical populations (panels a and b), by MBT types (panels c and d), and by control types (panels e and f). Legends:
SMD= standardized mean difference. MBT=mind-body therapies. P-values adjacent to I-squared results are p-values for heterogeneity testing (P,
0.05 indicates significant heterogeneity and ‘‘I-squared= n/a’’ indicates that there was only 1 study in the subgroup so heterogeneity was not
applicable), and p-values adjacent to meta-analysis pooled results (diamonds) are p-values for the pooled effect sizes.
doi:10.1371/journal.pone.0100903.g003
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insight into the potential mechanisms behind mind-body treat-
ment and the numerous health benefits they confer
Indeed, evidence accrued from 34 RCTs indicates that Tai Chi,
Qi Gong, meditation, and Yoga, both short- and long-term,
appear to reduce markers of inflammation and influence virus-
specific immune responses to vaccinations, despite minimal
evidence suggesting effects on resting anti-viral immunity or
enumerative measures among 2219 healthy individuals and those
with disease conditions. Specifically, for inflammatory measures,
18 published RCTs reported that 7 to 16 weeks of mind-body
interventions significantly reduced C-reactive protein, and pro-
duced a small but nonsignificant reduction of IL-6, as well as a
negligible effect on TNF-a. For anti-viral related immune and
enumerative measures, among 21 trials there were negligible
effects on CD4 count and natural killer cell counts with some
evidence that mind-body interventions increase immune responses
to vaccination. Our exploratory subgroup meta-analyses suggest
that the possible contribution of Tai Chi or Qi Gong exercise to
the immune outcomes, as its pooled effect size was larger than that
of meditation. However, these differences in effect size may in part
be explained by the heterogeneity in control conditions or
populations studied.
Our findings are supported by existing literature evaluating the
immunomodulatory effects of other types of behavioral interven-
tions including exercise, stress reduction, and mood modifying
approaches. For example, exercise, one of the most widely-studied
behavioral interventions, has been shown to reduce chronic
inflammation, enhance immunological memory in the context of
vaccination, and even reduce sick days associated with the
common cold and other upper respiratory tract infections
[17,29,75]. Furthermore, we compared our meta-analysis results
of the MBTs on CRP and IL-6 to other recognized interventions
such as weight loss and lifestyle changes on vascular inflammatory
markers in obese women (Esposito et al.) [76]. To perform this
comparison, we converted data from Esposito et al. into
standardized effect sizes (Cohen’s d). The results suggested that
MBTs have a larger effect size (pooled effect size = 0.58; P= 0.035)
than weight loss (effect size = 0.18; P= 0.008) on CRP, while the
benefits are comparable on IL-6 (pooled effect size = 0.35;
P= 0.09) versus weight loss (effect size = 0.349; P= 0.009) [76].
Major life adversities and psychological stress such as
depression have divergent effects on the immune system; anti-
viral immunity and resistance to infectious disease are reduced,
whereas markers of inflammation and risk of inflammation
associated disease are increased [28,32,75,77,78]. Initial efforts to
understand this pattern of infectious- vs. inflammation- associated
disease were unsuccessful by their focus on HPA axis activation
and glucocorticoid-mediated suppression of an immune response
in which both anti-viral and inflammatory responses are reduced
[28]. In contrast, the sympathetic nervous system (SNS) has been
found to inhibit anti-viral genes and to activate pro-inflammatory
genes. For example, b-adrenergic signaling reduces anti-viral or
adaptive immune responses by suppressing Th1-type gene
expression (such as IFNG and IL-12B) and by stimulating
transcription of T helper 2 (Th2)-type cytokine genes (such as
IL-4 and IL-5) [79–81]. Adrenergic signaling also leads to up-
regulated transcription of pro-inflammatory cytokines such as IL-
1B, TNF and IL-6 [82,83], consistent with evidence that acute
Figure 4. Meta-analysis of RCTs comparing the effect of mind-body therapies with control interventions on enumerative markers:
CD4 count (panel a) and NK count (panel b). Legends: CD4= cluster of differentiation 4 protein; Med=meditation; NK count = natural killer cell
count; Tx = treatment; SMD= standardized mean.
doi:10.1371/journal.pone.0100903.g004
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psychological stress increases circulating levels of IL-6 and IL-1b
[84]. However, other studies have found that adrenergic signaling
can increase, as well as inhibit the production of IL-6 and TNF
[85–89]. Nevertheless, adrenergic activation increases NF-kB in
peripheral blood mononuclear cells (PBMCs) [84,90,91], and
primes increases in the ex vivo production of pro-inflammatory
cytokines in response to stimulation to lipopolysaccharide (LPS)
and other Toll-like receptor ligands [90,92–95]. Finally, social
stressors that act in the long-term also lead to increased
expression of pro-inflammatory immune response genes despite
the presence of stable or elevated glucocorticoid levels [32,75,96–
98]. To the extent that mind-body interventions are able to
reverse the effects of acute and chronic stress and reduce SNS
activation [99], a reversal of the anti-viral and inflammatory
transcriptional bias of stress on immune response genes has been
found [37,100–102]. Indeed, both Tai Chi and mindfulness
based meditation can reduce pro-inflammatory response gene
profiles [37,102], and a Yogic meditation appears to reverse
increased NF-kB-related transcription of pro-inflammatory cyto-
kines and decreased IRF1-related transcription of innate antiviral
response genes [101].
Apparently, powerful links exist between the brain and the
immune system, and psychosocial factors can directly influence
health through behavior. MBTs may buffer these immune
alterations through relaxation, stress reduction, improved mood,
and moderate physical activity. Behavioral responses are therefore
the key to activating neuroendocrine and autonomic pathways,
which in turn modulate the immune system and have implications
for susceptibility to a variety of diseases. These changes
foreshadow a synergistic effect on down-regulating the sympathet-
ic nervous system, causing diminished pro-inflammatory gene
response [17,29–31,84]. Thus, behavioral interventions that alter
immune responses provide potent evidence for psychological
influences on immune function.
Our study is limited in a few important ways. First, studies were
heterogeneous with regards to population characteristics, partic-
ularly with regard to age and health status, which limit the
generalizability of our findings. Furthermore, it is possible that
only populations under stress psychologically, physiologically, or
with an inflammatory condition, will reveal changes in the
immune markers measured in response to MBTs. Second,
interventions were heterogeneous with regard to type, frequency,
and duration. Moreover, the mind-body therapies may not have
been administered at a sufficient dose or for sufficient duration to
affect immune changes. In addition, we are unable to make any
determination as to whether immunological outcomes resulted
from a single component of the multi-dimensional intervention or
rather from the intervention as a whole. Third, the outcome itself
may not be sensitive to change with MBTs. For example, CRP is
an acute phase protein that is induced by IL-6, and increases of
CRP occur only following robust activation of IL-6.
Despite limitations, further methodologically rigorous evalua-
tion of the effects MBTs on the immune system are warranted with
emphasis on clinically applicable outcomes. In the future, mind-
body studies should focus on elderly and clinical populations with
identified immune deregulation to better elucidate potential
implications for clinical outcomes. For example, such mind-body
studies should test the effects of MBTs among populations with
pro-inflammatory states such as infection, neoplasm, inflammatory
arthritis, infarction, and tissue injury. Moreover, understanding
dose response relationship and critical components of mind-body
interventions associated with changes in hormone levels, inflam-
matory outcomes, and antiviral outcomes will be beneficial to
understanding and unraveling mechanistic pathways
In summary, MBTs impact inflammatory measures and may
influence virus-specific, cell-mediated immune responses to
vaccination; there is minimal evidence to suggest effects on other
related enumerative measures. Further understanding of the
effects of MBTs on the immune system and clinical outcomes
will provide insight into and affirm the phenomenon of
complementary and alternative medicine therapeutic concepts,
thus establishing a new paradigm for understanding health and
treating illness.
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